BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22186078)

  • 1. [National Campaign of Vaccination against the flu A (H1N1)v: National Follow-up of Pharmacovigilance].
    Durrieu G; Caillet C; Lacroix I; Jacquet A; Faucher A; Ouaret S; Sommet A; Perault-Pochat MC; Kreft-Jaïs C; Castot A; Damase-Michel C; Montastruc JL;
    Therapie; 2011; 66(6):527-40. PubMed ID: 22186078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacovigilance study of influenza A H1N1 vaccination during the 2009-2010 season in France].
    Montastruc JL;
    Bull Acad Natl Med; 2011 Jun; 195(6):1309-16; discussion 1316-7. PubMed ID: 22530521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First French experience of ADR reporting by patients after a mass immunization campaign with Influenza A (H1N1) pandemic vaccines: a comparison of reports submitted by patients and healthcare professionals.
    Durrieu G; Palmaro A; Pourcel L; Caillet C; Faucher A; Jacquet A; Ouaret S; Perault-Pochat MC; Kreft-Jais C; Castot A; Lapeyre-Mestre M; Montastruc JL;
    Drug Saf; 2012 Oct; 35(10):845-54. PubMed ID: 22967189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two doses of pandemic influenza A(H1N1) vaccine: tolerability in healthy young children in the Netherlands.
    van't Klooster TM; Kemmeren JM; de Melker HE; Vermeer-de Bondt PE; van der Maas NA
    Hum Vaccin; 2011 Oct; 7(10):1048-54. PubMed ID: 21957494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High coverage and safety of influenza A (H1N1) 2009 monovalent vaccination among health care personnel in Thailand.
    Kiertiburanakul S; Malathum K; Watcharananan SP; Bunupuradah P; Piebpien P; Rujiraviroj U; Likitsinsipon W; Apivanich S; Kehachindawat P; Burakitcharoen R; Leelaudomlipi S; Wananukul W
    Am J Infect Control; 2011 Aug; 39(6):525-8. PubMed ID: 21612842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse events following pandemic influenza vaccine Pandemrix® reported in the French military forces--2009-2010.
    Mayet A; Ligier C; Gache K; Manet G; Nivoix P; Dia A; Haus-Cheymol R; Verret C; Duron S; Faure N; Piarroux M; De Laval F; Simon F; Decam C; Chaudet H; Meynard JB; Rapp C; Deparis X; Migliani R
    Vaccine; 2011 Mar; 29(14):2576-81. PubMed ID: 21296693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: a multinational self-controlled case series in Europe.
    Romio S; Weibel D; Dieleman JP; Olberg HK; de Vries CS; Sammon C; Andrews N; Svanström H; Mølgaard-Nielsen D; Hviid A; Lapeyre-Mestre M; Sommet A; Saussier C; Castot A; Heijbel H; Arnheim-Dahlström L; Sparen P; Mosseveld M; Schuemie M; van der Maas N; Jacobs BC; Leino T; Kilpi T; Storsaeter J; Johansen K; Kramarz P; Bonhoeffer J; Sturkenboom MC
    PLoS One; 2014; 9(1):e82222. PubMed ID: 24404128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety monitoring of Influenza A/H1N1 pandemic vaccines in EudraVigilance.
    Kurz X; Domergue F; Slattery J; Segec A; Szmigiel A; Hidalgo-Simon A
    Vaccine; 2011 Jun; 29(26):4378-87. PubMed ID: 21501644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pandemic 2009 H1N1 influenza virus vaccination in lung transplant recipients: coverage, safety and clinical effectiveness in the Zurich cohort.
    Schuurmans MM; Tini GM; Dalar L; Fretz G; Benden C; Boehler A
    J Heart Lung Transplant; 2011 Jun; 30(6):685-90. PubMed ID: 21444211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Guillain-Barre syndrome and the mass vaccination against A/H1N1. No increase of the risk has been reported so far].
    Press R; Andersen O
    Lakartidningen; 2010 Mar 10-16; 107(10):666-7. PubMed ID: 20402249
    [No Abstract]   [Full Text] [Related]  

  • 11. [First season of pandemic influenza A/H1N1].
    Weil-Olivier C
    Rev Prat; 2010 Dec; 60(10):1388-91, 1394-8. PubMed ID: 21425535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [H1N1 influenza vaccines in Tunisia: efficiency and safety].
    Chaabane A; Aouam K; Ben Fredj N; Toumi A; Braham D; A Boughattas N; Chakroun M
    Therapie; 2011; 66(3):281-9. PubMed ID: 21819811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Jun; 59(21):657-61. PubMed ID: 20520590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guillain-Barré syndrome after H1N1 vaccination in the United States: a report using the CDC/FDA Vaccine Adverse Event Reporting System (2009).
    Souayah N; Yacoub HA; Khan HM; Michas-Martin PA; Menkes DL; Maybodi L; Qureshi AI
    Neuroepidemiology; 2012; 38(4):227-32. PubMed ID: 22555646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of narcolepsy in Norwegian children and adolescents after vaccination against H1N1 influenza A.
    Heier MS; Gautvik KM; Wannag E; Bronder KH; Midtlyng E; Kamaleri Y; Storsaeter J
    Sleep Med; 2013 Sep; 14(9):867-71. PubMed ID: 23773727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fever following immunization with influenza A (H1N1) vaccine in children: a survey-based study in the Netherlands.
    Broos N; van Puijenbroek EP; van Grootheest K
    Drug Saf; 2010 Dec; 33(12):1109-15. PubMed ID: 21077701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-adjuvanted 2009 influenza A (H1N1)v vaccine in pregnant women: the results of a French prospective descriptive study.
    Omon E; Damase-Michel C; Hurault-Delarue C; Lacroix I; Montastruc JL; Oustric S; Escourrou B
    Vaccine; 2011 Dec; 29(52):9649-54. PubMed ID: 22036887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring adverse events of vaccines against Mexican flu.
    van Puijenbroek EP; van Grootheest AC
    Int J Risk Saf Med; 2011; 23(2):81-7. PubMed ID: 21673415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guillain-Barre syndrome, influenzalike illnesses, and influenza vaccination during seasons with and without circulating A/H1N1 viruses.
    Grimaldi-Bensouda L; Alpérovitch A; Besson G; Vial C; Cuisset JM; Papeix C; Lyon-Caen O; Benichou J; Rossignol M;
    Am J Epidemiol; 2011 Aug; 174(3):326-35. PubMed ID: 21652600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.